Skip to main content
. 2020 Jan 31;60(4):191–201. doi: 10.2176/nmc.oa.2019-0267

Table 2.

Revascularization procedures and treatment results

Total

N 3705

IV rt-PA (%) 1346/3572 (37.7)
EVT procedures (%) (n = 3676)
    Stand-alone IAT 359 (9.8)
    Stand-alone PTA/BCD 332 (9.0)
    Stand-alone thrombectomy using the Merci retriever 420 (11.4)
    Stand-alone thromboaspiration using the Penumbra catheter 783 (21.3)
    Stand-alone thrombectomy using other than the Merci retriever 236 (6.4)
    Stand-alone stenting 141 (3.8)
    Other single procedures 102 (2.8)
    Any procedural combinations 1303 (35.4)
  Any combination including IAT 884 (24.0)
  Any combination including PTA/BCD 966 (26.3)
  Any combination including the Merci retriever 888 (24.2)
  Any combination including the Penumbra catheter 1452 (39.5)
  Any combination including thrombectomy devices other than the Merci retriever 377 (10.3)
  Any combination including stenting 426 (11.6)
Successful reperfusion (%) 2166/3657 (59.2)
  TICI 3 1001 (27.4)
Procedure-related intracranial hemorrhagic complications 353/3692 (9.6)
Clinical outcome at 30 days (%) (n = 3608)
  Favorable 1100 (30.5)
  Death 402 (11.1)

EVT: endovascular therapy, IAT: intra-arterial thrombolysis, IV rt-PA: intravenous recombinant tissue-plasminogen activator, PTA/BCD: percutaneous transluminal angioplasty/balloon clot disruption, TICI: Thrombolysis in Cerebral Infarction.